| Cash Flow | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Net income | 5,014 | 3,041 | 1,409 | 2,242 |
| Depreciation and amortization | 2,053 | 1,356 | 674 | 2,129 |
| Realized investment losses, net | - | - | - | -2,805 |
| Investment (gains) losses, net | 76 | 50 | -2 | - |
| Deferred income tax benefit | 174 | 292 | 216 | 351 |
| (gain) loss on sale of businesses | 79 | 41 | 41 | -106 |
| Accounts receivable, net | 6,911 | 6,398 | 2,205 | 10,600 |
| Inventories | -1,060 | -726 | -1,517 | -577 |
| Reinsurance recoverable and other assets | 537 | 402 | 219 | 358 |
| Insurance liabilities | 1,662 | 1,702 | 1,778 | -214 |
| Pharmacy and other service costs payable | 1,837 | 995 | 135 | 8,979 |
| Accounts payable and accrued expenses and other liabilities | -857 | -1,020 | -1,174 | -819 |
| Other, net | -460 | -417 | -260 | -655 |
| Net cash provided by operating activities | 3,452 | 34 | 1,920 | 5,151 |
| Debt securities and equity securities | 518 | 272 | 94 | 569 |
| Debt securities and equity securities | 745 | 553 | 222 | 585 |
| Commercial mortgage loans | 198 | 90 | 85 | 79 |
| Other sales, maturities and repayments (primarily short-term and other long-term investments) | 656 | 431 | 331 | 567 |
| Debt securities and equity securities | 5,271 | 1,512 | 952 | 943 |
| Commercial mortgage loans | 117 | 62 | 34 | 54 |
| Other (primarily short-term and other long-term investments) | 1,066 | 761 | 475 | 1,028 |
| Property and equipment purchases, net | 890 | 612 | 327 | 1,069 |
| Acquisitions, net of cash acquired | 597 | - | - | 132 |
| Divestitures, net of cash sold | 2,346 | 2,346 | 2,346 | 0 |
| Renewable energy tax credit equity investments | 485 | 327 | 92 | - |
| Other, net | 24 | 18 | 1 | 485 |
| Net cash used in investing activities | -3,987 | 400 | 1,197 | -1,911 |
| Deposits and interest credited to contractholder deposit funds | 113 | 74 | 36 | 120 |
| Withdrawals and benefit payments from contractholder deposit funds | 201 | 137 | 64 | 180 |
| Net change in short-term debt, excluding term loan | -915 | 296 | -891 | 366 |
| Net proceeds on issuance of term loan | 1,999 | - | - | - |
| Repayment of term loan | 2,000 | - | - | - |
| Repayment of long-term debt | 1,643 | 1,600 | 700 | 3,000 |
| Net proceeds on issuance of long-term debt | 4,461 | 0 | 0 | 4,462 |
| Repurchase of common stock | 2,620 | 2,620 | 1,508 | 5,012 |
| Issuance of common stock | 178 | 141 | 69 | 283 |
| Common stock dividend paid | 1,215 | 813 | 412 | 1,183 |
| Other, net | -512 | -355 | -211 | -255 |
| Net cash used in financing activities | -2,355 | -5,014 | -3,681 | -4,399 |
| Effect of foreign currency rate changes on cash, cash equivalents and restricted cash | 30 | 35 | 9 | 6 |
| Net decrease in cash, cash equivalents and restricted cash | -2,860 | -4,545 | -555 | -1,153 |
| Cash and cash equivalents at beginning of period | 8,931 | 8,931 | 8,931 | 8,337 |
| Cash and cash equivalents at end of period | 6,071 | 4,386 | 8,376 | 7,184 |
Cigna Group (CI)
Cigna Group (CI)